paediatricsatic and geriatrics

Asking for Preferences

Difference

Asking for Preferences

paediatricsatic and geriatrics Difference

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Reading File
Now I have enough solid textbook content to write a thorough comparison. Here is the full answer:

Paediatrics vs. Geriatrics - Key Differences

These two specialties both deal with populations whose physiology, pharmacology, and disease patterns differ from healthy adults, but in opposite directions - one involves development and maturation, the other involves decline and multi-system degeneration.

1. Definition & Age Groups

FeaturePaediatricsGeriatrics
PopulationChildren from birth to ~18 yearsAdults typically ≥65 years (often ≥75 for geriatric syndromes)
Core processGrowth, development, maturationAgeing, functional decline, frailty
Sub-groupsNeonates, infants, toddlers, school-age, adolescentsYoung-old (65-74), old (75-84), oldest-old (≥85)

2. Physiology

Paediatrics

  • Organ systems are immature and still developing
  • Higher metabolic rate and body surface area-to-weight ratio
  • Thinner stratum corneum - greater risk of systemic toxicity from topical drugs
  • Immature blood-brain barrier - risk of kernicterus (e.g., from ceftriaxone in neonates)
  • Decreased gastric emptying and higher gastric pH in neonates - prolongs drug exposure before pylorus passage
  • Immune system immature - higher susceptibility to certain infections

Geriatrics

  • Organ function declines at ~1% per year after age 30 (Goldman-Cecil Medicine)
  • Reduced cardiac reserve, renal function, hepatic metabolism, pulmonary capacity
  • Sarcopenia (muscle loss), osteopenia/osteoporosis
  • Decreased thirst sensation - risk of dehydration
  • Reduced baroreflex sensitivity - orthostatic hypotension

3. Pharmacokinetics (Drug Handling)

Paediatrics

  • Absorption: Slower gastric emptying, higher pH in neonates alters oral drug absorption
  • Distribution: Higher total body water, lower plasma protein (altered drug distribution); weight-based dosing is essential but must account for age-related renal development - not just weight (e.g., gentamicin dosing)
  • Metabolism: Immature hepatic enzyme systems (CYP enzymes); e.g., codeine via CYP2D6 ultrarapid metabolism can cause fatal morphine toxicity in neonates
  • Excretion: Immature renal function, especially in neonates - drugs eliminated more slowly
Key point: Adult pharmacokinetic data cannot simply be extrapolated to children because of developmental differences in both pharmacokinetics and pharmacodynamics - Rosen's Emergency Medicine, p. 3322; Kaplan & Sadock's Psychiatry.

Geriatrics

  • Reduced renal clearance - many drugs accumulate (e.g., digoxin, aminoglycosides, NSAIDs)
  • Reduced hepatic first-pass metabolism - higher bioavailability of some oral drugs
  • Increased body fat, decreased lean mass - lipophilic drugs have longer half-lives
  • Reduced albumin in frail elderly - more free (active) drug for highly protein-bound drugs
  • Polypharmacy is the norm (64% of adults ≥65 have ≥2 chronic conditions) - drug interactions are common

4. Disease Patterns

Paediatrics

  • Congenital/genetic disorders (heart disease, metabolic disorders, chromosomal syndromes)
  • Infectious diseases - RSV, rotavirus, meningitis, otitis media
  • Developmental disorders - autism, ADHD, cerebral palsy
  • Malignancies - leukaemia, brain tumours, Wilms tumour (childhood-specific)
  • Asthma, febrile seizures, failure to thrive
  • Acute illnesses tend to be single-system in younger children

Geriatrics

  • Multimorbidity is the rule - at age ≥65, 64% have ≥2 chronic conditions vs. only 7% of those aged 18-44 (Goldman-Cecil Medicine, Table 22-1)
  • Cardiovascular disease - hypertension, heart failure, atrial fibrillation, coronary artery disease
  • Neurodegenerative diseases - Alzheimer's, Parkinson's, vascular dementia
  • Metabolic - type 2 diabetes, hypothyroidism, osteoporosis
  • Geriatric syndromes (unique to this population): falls, delirium, frailty, urinary incontinence, pressure ulcers, malnutrition, cognitive impairment - these arise from accumulated impairments across multiple domains, not a single disease

5. Drug Safety Concerns - Specific Examples

Paediatric-Specific Drug Toxicities (from Rosen's Emergency Medicine)

DrugConcern
CodeineCYP2D6 ultrarapid metabolism - fatal morphine toxicity; NOT recommended in paediatrics
AspirinReye syndrome during viral illness
DoxycyclinePermanent tooth discoloration
CeftriaxoneKernicterus in neonates <28 days
PhenothiazinesApnea/severe respiratory depression
TMP-SMXBilirubin displacement, kernicterus in <2 months

Geriatric-Specific Drug Risks

  • NSAIDs - GI bleeding, renal failure, fluid retention
  • Benzodiazepines - falls, delirium, prolonged sedation
  • Anticholinergics - confusion, urinary retention, constipation
  • Antihypertensives - orthostatic hypotension and falls
  • Anticoagulants - bleeding risk higher due to polypharmacy interactions

6. Assessment Approaches

PaediatricsGeriatrics
Growth monitoringWeight, height, head circumference centilesNot applicable
Developmental milestonesMotor, speech, cognitive, social milestonesNot applicable
Functional assessmentSchool performance, playADLs/IADLs, gait speed, cognition (MMSE/MoCA)
Screening toolsDenver Developmental ScreeningGeriatric Assessment - frailty, falls risk, polypharmacy review
Family involvementParental consent/history criticalCaregiver burden, advance care planning

7. Key Philosophical Differences

DimensionPaediatricsGeriatrics
TrajectoryUpward (growth, gaining function)Downward (decline, losing function)
GoalNormal development and disease preventionMaintaining independence, quality of life, preventing decline
ConsentParental/guardian (child assents when able)Patient (with capacity assessment; proxy if needed)
Drug labelling gapsMost drugs studied in adults; paediatric data often missingElderly often excluded from trials; evidence gaps common
End-of-lifeRare (terminal illness in childhood)Central concern; advance directives, palliative care

Sources:
  • Rosen's Emergency Medicine (paediatric pharmacokinetics, drug toxicity table, p. 3322)
  • Goldman-Cecil Medicine (geriatric syndromes, multimorbidity table, geriatric assessment, p. 235-237)
  • Kaplan & Sadock's Comprehensive Textbook of Psychiatry (paediatric drug dosing and PK extrapolation)

For 2 marks viva

Here is a crisp, viva-ready 2-mark answer:

Differences Between Paediatrics and Geriatrics

FeaturePaediatricsGeriatrics
Age groupBirth to 18 years65 years and above
Physiological processGrowth & development (immature organs)Ageing & decline (degenerating organs)
PharmacokineticsImmature liver/kidney - slower drug metabolismReduced renal/hepatic clearance - drug accumulation
Drug dosingWeight-based (mg/kg)Reduced doses due to organ decline
Disease patternCongenital, infectious, developmentalChronic, degenerative, multimorbidity
PolypharmacyUncommonVery common
ConsentParent/guardian gives consentPatient gives consent (capacity assessed)
GoalAchieve normal growth & developmentMaintain independence & quality of life

One-line viva answer:
Paediatrics deals with growing, immature organ systems in children requiring weight-based dosing, while geriatrics deals with declining, degenerated organ systems in the elderly requiring dose reduction and polypharmacy management.

Brest feeding which drug decrease it

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Excellent textbook content found. Here is the complete answer:

Drugs That Decrease Breast Feeding (Reduce Milk Production / Suppress Lactation)

Mechanism First (Important for Viva)

Breast milk production depends on prolactin from the anterior pituitary. Prolactin is normally inhibited by dopamine from the hypothalamus. So any drug that increases dopamine activity (dopamine agonists) will reduce prolactin → reduce milk production.

Drugs That Decrease Breast Milk

1. Dopamine Agonists (Most Important Group)

DrugUse
BromocriptineClassic drug to suppress lactation (inhibits prolactin directly)
CabergolineMore potent, longer-acting; preferred over bromocriptine
LevodopaIncreases dopamine, reduces prolactin
"Dopamine agonists such as bromocriptine inhibit prolactin secretion" - Costanzo Physiology, 7th Ed.

2. Estrogens

  • High-dose estrogen (e.g., combined oral contraceptive pills) suppresses lactation
  • Mechanism: directly inhibits milk secretion at breast tissue level
  • Low-dose progestin-only pills are safe during breastfeeding

3. Pseudoephedrine / Decongestants

  • Reduces milk supply by vasoconstriction and direct glandular effect
  • Even a single dose can reduce output

4. Diuretics

  • Furosemide in high doses - reduces fluid available for milk
  • Thiazides can also reduce milk volume

5. Ergotamine

  • Dopaminergic activity - used in the past to suppress lactation

6. Alcohol (chronic heavy use)

  • Inhibits oxytocin release - impairs milk ejection (let-down reflex)

7. Drugs that increase Dopamine (indirectly)

  • Amphetamines, cocaine - dopaminergic, reduce prolactin

Memory Table

Drug/GroupMechanism
Bromocriptine / CabergolineDopamine agonist → ↓ Prolactin
Estrogens (high dose)Direct suppression of milk secretion
PseudoephedrineVasoconstriction + glandular suppression
FurosemideFluid depletion
Alcohol (excess)↓ Oxytocin → impairs let-down

Prolactin Inhibitory Factors (Table from Costanzo Physiology)

Stimulate Prolactin (↑ milk)Inhibit Prolactin (↓ milk)
Pregnancy, breastfeedingDopamine
Sleep, stressBromocriptine (dopamine agonist)
TRHSomatostatin
Dopamine antagonistsProlactin itself (negative feedback)

Viva one-liner:
Dopamine agonists (bromocriptine, cabergoline) are the main drugs that decrease breastfeeding by inhibiting prolactin secretion from the anterior pituitary.

Laction period contraindication drug

Finding Sources
Finding Sources
Reading File
Finding Sources
I have the WHO classification directly from the textbook. Here is the complete answer:

Drugs Contraindicated During Lactation

Mechanism of Transfer

Drugs pass into breast milk mainly by passive diffusion. Factors favouring transfer:
  • Low molecular weight
  • High lipid solubility
  • Low protein binding
  • Unionized form (high pKa for bases)

WHO Classification - Drugs & Breastfeeding

(Tintinalli's Emergency Medicine, Table 99-7)
CategoryDrugs
Breastfeeding CONTRAINDICATEDAnticancer drugs, Radioactive substances, Amphetamines, Ergotamines, Statins, Nitrofurantoin (in infants <1 month or with G6PD deficiency)
Avoid unless absolutely necessaryChloramphenicol, Tetracyclines, Fluoroquinolones
Monitor infant for drowsinessPsychiatric drugs (benzodiazepines, antipsychotics), Anticonvulsants
Monitor infant for jaundiceSulfonamides, Dapsone, Mefloquine, Fansidar
May inhibit lactationEstrogens, Thiazides

Detailed List by Drug Class

Absolutely Contraindicated

DrugReason
Cytotoxic/Anticancer drugs (methotrexate, cyclophosphamide)Immunosuppression, bone marrow suppression in infant
Radioactive iodine (I-131)Thyroid ablation in infant
Bromocriptine / CabergolineSuppresses lactation (stops milk)
AmphetaminesCNS stimulation, poor feeding in infant
ErgotamineVomiting, diarrhoea, convulsions in infant
Statins (atorvastatin, rosuvastatin)Risk of disrupting infant lipid metabolism
Cocaine, heroinInfant addiction, CNS toxicity

Avoid (Use Only if No Alternative)

DrugReason
ChloramphenicolGrey baby syndrome, bone marrow toxicity
TetracyclinesTooth discoloration, bone growth inhibition
Fluoroquinolones (ciprofloxacin)Cartilage damage in infant joints
MethotrexateFolate antagonism, immunosuppression
LithiumInfant toxicity - cyanosis, hypotonia
Iodine-containing drugs (amiodarone)Infant hypothyroidism

Use With Caution / Monitor Infant

DrugEffect to Watch
BenzodiazepinesInfant sedation, respiratory depression
Antipsychotics (haloperidol, clozapine)Drowsiness, developmental effects
Phenobarbitone, phenytoinSedation, poor suckling
Sulfonamides, DapsoneHaemolysis, jaundice (esp. G6PD deficiency)
Aspirin (high dose)Reye syndrome, platelet dysfunction
CodeineMorphine toxicity in ultra-rapid metabolisers

Drugs SAFE in Lactation (for comparison)

  • Paracetamol (acetaminophen)
  • Penicillins, cephalosporins
  • Heparin (does not cross into milk)
  • Insulin
  • Progestin-only contraceptives
  • Loratadine (antihistamine)

Viva One-Liner

Drugs absolutely contraindicated in lactation include anticancer drugs, radioactive iodine, amphetamines, ergotamines, statins, and chloramphenicol - they either harm the infant directly or suppress milk production.
Source: Tintinalli's Emergency Medicine, WHO Table 99-7 on Drugs and Breastfeeding
This is a shared conversation. Sign in to Orris to start your own chat.